- Home
- » Tags
- » Brasofensine
Top View
- (12) United States Patent (10) Patent No.: US 9,084.825 B2 Montefeltro Et Al
- Wo 2007/148341 A2
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
- Substrate and Drug Binding Sites in Leut Ajeeta Nyola1, Nathan K Karpowich1, Juan Zhen2, Jennifer Marden1, Maarten E Reith2 and Da-Neng Wang1
- Official Journal L 175
- Official Journal of the European Communities 10. 7
- Tesofensine (NS 2330), a Monoamine Reuptake Inhibitor, in Patients with Advanced Parkinson Disease and Motor Fluctuations the ADVANS Study
- Customs Tariff - Schedule Xxi - 1
- Harmonized Tariff Schedule of the United States (2006) (Rev
- WO 2016/135707 Al 1 September 2016 (01.09.2016) P O P C T
- (12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
- Table [1]: Definition of Reported Outcomes Study Outcome
- Pharmaceutical Appendix to the Tariff Schedule 2
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
- Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Federal Register/Vol. 64, No. 13/Thursday, January 21, 1999/Notices
- Combination of Morphinan Compounds and Antidepressant for the Treatment of Pseudobulbar Affect